- Definitive Healthcare press release ( NASDAQ: DH ): Q3 Non-GAAP EPS of $0.06 beats by $0.01 .
- Revenue of $57.4M (+33.2% Y/Y) beats by $0.67M .
- Q4 Revenue is expected to be in the range of $58-59 million, a median 26% increase year over year. Consensus of $61.81M.Adjusted Net Income Per Diluted Share is expected to be $0.03-0.04 on approximately 156.5 million weighted-average shares outstanding. Consensus of $0.05.
- FY22 Revenue is expected to be in the range of $220 – $221 million, an increase of 33% from prior year at the midpoint. Consensus of $222.65M. Adjusted Net Income Per Diluted Share is expected to be $0.19– $0.20 on approximately 155.3 million weighted-average shares outstanding. Consensus of $0.21.
- Shares -9.62% .
For further details see:
Definitive Healthcare Non-GAAP EPS of $0.06 beats by $0.01, revenue of $57.4M beats by $0.67M